Advertisement
Eli Lilly and Co posted a rally over the past five days, gaining 75.31 USD, or 9.38%, to close at 878.31 USD on February 7 at 6:45 PM GMT-5. The stock demonstrated a positive momentum throughout the week after the drug maker company released its fourth quarter earnings that beat Wall Street expectations
During the latest trading session, Eli Lilly opened at 876.53 USD. The stock climbed to a session high of 889.36 USD. However, the intraday low of 869.62 USD suggested some volatility.
After-hours trading saw a marginal decline, with the stock slipping 0.22 USD, or 0.025%, to 878.09 USD. Eli Lilly maintained a substantial market capitalization of 83.38KCr, reinforcing its position as a leading player in the pharmaceutical sector. The stock found resistance near 889.36 USD, where some selling emerged, while support at 869.62 USD helped maintain its gains.
Disclaimer: This article is for informational purposes only and does not constitute any financial advice.